Pharmacology, Toxicology and Pharmaceutical Science
Antiapoptotic
100%
Cyclin Dependent Kinase Inhibitor
100%
Cyclin Dependent Kinase 9
100%
Inflammatory Disease
50%
Rheumatoid Arthritis
50%
Inflammatory Arthritis
50%
Cyclin Dependent Kinase
50%
Protein Mcl 1
50%
Cyclin T1
50%
Flavopiridol
50%
Roscovitine
50%
Diseases
50%
Keyphrases
Neutrophils
100%
Cyclin-dependent Kinase 9 (CDK9)
100%
Spontaneous Apoptosis
100%
Apoptosis
50%
Anti-apoptotic Proteins
25%
Neutrophil Apoptosis
25%
Cyclin-dependent Kinase Inhibitor
25%
Myeloid Cell leukemia-1 (Mcl-1)
25%
Rheumatoid Arthritis
12%
Chronic Inflammatory Diseases
12%
Leukocytes
12%
Human Neutrophils
12%
Short Half-life
12%
Novel Therapeutic Targets
12%
Immune Defense
12%
CDK9 Inhibitor
12%
Transcriptional Regulation
12%
CDK7
12%
Cyclin-dependent Kinase
12%
Positive Transcription Elongation Factor b (P-TEFb)
12%
Rapid Decline
12%
Cyclin T1
12%
R-roscovitine
12%
Flavopiridol
12%
Cyclin-dependent Kinase 5 (Cdk5)
12%
Short Lifetime
12%
Biochemistry, Genetics and Molecular Biology
Cyclin-Dependent Kinase
100%
Cyclin-Dependent Kinase 9
100%
Programmed Cell Death
100%
Lifespan
85%
Immunity
14%
Leukocyte
14%
P-TEFb
14%
Cyclin T1
14%
Immunology and Microbiology
Neutrophil
100%
Cycline
100%
Programmed Cell Death
100%
Lifespan
54%
Inflammatory Arthritis
9%
Inflammatory Disorder
9%
Leukocyte
9%
Immunity
9%
Cyclin T1
9%